These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15533443)

  • 1. Direct observation of Abeta amyloid fibril growth and inhibition.
    Ban T; Hoshino M; Takahashi S; Hamada D; Hasegawa K; Naiki H; Goto Y
    J Mol Biol; 2004 Nov; 344(3):757-67. PubMed ID: 15533443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct observation of amyloid growth monitored by total internal reflection fluorescence microscopy.
    Ban T; Goto Y
    Methods Enzymol; 2006; 413():91-102. PubMed ID: 17046392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct observation of amyloid fibril growth, propagation, and adaptation.
    Ban T; Yamaguchi K; Goto Y
    Acc Chem Res; 2006 Sep; 39(9):663-70. PubMed ID: 16981683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization and classification of amyloid beta supramolecular assemblies.
    Yagi H; Ban T; Morigaki K; Naiki H; Goto Y
    Biochemistry; 2007 Dec; 46(51):15009-17. PubMed ID: 18044976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
    Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
    Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
    Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
    Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol derivatives inhibit the fibril formation of amyloid-beta peptides.
    Huong VT; Shimanouchi T; Shimauchi N; Yagi H; Umakoshi H; Goto Y; Kuboi R
    J Biosci Bioeng; 2010 Jun; 109(6):629-34. PubMed ID: 20471605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.
    Ouberai M; Dumy P; Chierici S; Garcia J
    Bioconjug Chem; 2009 Nov; 20(11):2123-32. PubMed ID: 19821579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin.
    Raman B; Ban T; Sakai M; Pasta SY; Ramakrishna T; Naiki H; Goto Y; Rao ChM
    Biochem J; 2005 Dec; 392(Pt 3):573-81. PubMed ID: 16053447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designed amyloid beta peptide fibril - a tool for high-throughput screening of fibril inhibitors.
    Dolphin GT; Ouberai M; Dumy P; Garcia J
    ChemMedChem; 2007 Nov; 2(11):1613-23. PubMed ID: 17876751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereospecific amyloid-like fibril formation by a peptide fragment of beta2-microglobulin.
    Wadai H; Yamaguchi K; Takahashi S; Kanno T; Kawai T; Naiki H; Goto Y
    Biochemistry; 2005 Jan; 44(1):157-64. PubMed ID: 15628856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
    Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
    Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
    Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K
    Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils.
    Chen Z; Krause G; Reif B
    J Mol Biol; 2005 Dec; 354(4):760-76. PubMed ID: 16271725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine scanning mutagenesis of Abeta(1-40) amyloid fibril stability.
    Williams AD; Shivaprasad S; Wetzel R
    J Mol Biol; 2006 Apr; 357(4):1283-94. PubMed ID: 16476445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical unbinding of abeta peptides from amyloid fibrils.
    Raman EP; Takeda T; Barsegov V; Klimov DK
    J Mol Biol; 2007 Oct; 373(3):785-800. PubMed ID: 17868685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.
    Sheikh AM; Nagai A
    FEBS J; 2011 Feb; 278(4):634-42. PubMed ID: 21205198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding.
    Milton NG; Harris JR
    Micron; 2009 Dec; 40(8):800-10. PubMed ID: 19683452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.